220 related articles for article (PubMed ID: 35999224)
1. CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis.
Lv F; He Y; Xu H; Li Y; Han L; Yan L; Lang H; Zhao Y; Zhao Z; Qi Y
Cell Death Dis; 2022 Aug; 13(8):729. PubMed ID: 35999224
[TBL] [Abstract][Full Text] [Related]
2. Blockade of Notch1 Signaling Alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 Inflammasome Activation.
Wu D; Jiang T; Zhang S; Huang M; Zhu Y; Chen L; Zheng Y; Zhang D; Yu H; Yao G; Sun L
Inflammation; 2024 Apr; 47(2):649-663. PubMed ID: 38085465
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.
Guo C; Fu R; Zhou M; Wang S; Huang Y; Hu H; Zhao J; Gaskin F; Yang N; Fu SM
J Autoimmun; 2019 Sep; 103():102286. PubMed ID: 31133359
[TBL] [Abstract][Full Text] [Related]
4. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
He J; Sun M; Tian S
Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
[TBL] [Abstract][Full Text] [Related]
5. CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.
Zhao J; Rui HL; Yang M; Sun LJ; Dong HR; Cheng H
Mediators Inflamm; 2019; 2019():3172647. PubMed ID: 31097920
[TBL] [Abstract][Full Text] [Related]
6. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.
Fu R; Guo C; Wang S; Huang Y; Jin O; Hu H; Chen J; Xu B; Zhou M; Zhao J; Sung SJ; Wang H; Gaskin F; Yang N; Fu SM
Arthritis Rheumatol; 2017 Aug; 69(8):1636-1646. PubMed ID: 28544564
[TBL] [Abstract][Full Text] [Related]
7. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid alleviates lupus nephritis by suppressing SUMO1-mediated stabilization of NLRP3.
Chen L; Li F; Ni JH; Hao YX; Feng G; Shen XY; You Y
Phytomedicine; 2024 Jul; 130():155556. PubMed ID: 38810552
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 slows the progression of lupus nephritis by regulating the NLRP3 inflammasome through ROS/TRPM2/Ca
Tian J; Huang T; Chen J; Wang J; Chang S; Xu H; Zhou X; Yang J; Xue Y; Zhang T; Fan W; Wang Y
Clin Exp Med; 2023 Nov; 23(7):3465-3478. PubMed ID: 37261640
[TBL] [Abstract][Full Text] [Related]
10. GBP5 Inhibition Ameliorates the Progression of Lupus Nephritis by Suppressing NLRP3 Inflammasome Activation.
Liu N; Gao Y; Liu Y; Liu D
Immunol Invest; 2023 Jan; 52(1):52-66. PubMed ID: 36175170
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
[TBL] [Abstract][Full Text] [Related]
12. CD36 Promotes Podocyte Apoptosis by Activating the Pyrin Domain-Containing-3 (NLRP3) Inflammasome in Primary Nephrotic Syndrome.
Yang X; Wu Y; Li Q; Zhang G; Wang M; Yang H; Li Q
Med Sci Monit; 2018 Sep; 24():6832-6839. PubMed ID: 30258045
[TBL] [Abstract][Full Text] [Related]
13. Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice.
Lin TJ; Wu CY; Tsai PY; Hsu WH; Hua KF; Chu CL; Lee YC; Chen A; Lee SL; Lin YJ; Hsieh CY; Yang SR; Liu FC; Ka SM
Front Immunol; 2019; 10():1951. PubMed ID: 31475012
[TBL] [Abstract][Full Text] [Related]
14. Renal NLRP3 Inflammasome activation is associated with disease activity in lupus nephritis.
Chen FF; Liu XT; Tao J; Mao ZM; Wang H; Tan Y; Qu Z; Yu F
Clin Immunol; 2023 Feb; 247():109221. PubMed ID: 36610524
[TBL] [Abstract][Full Text] [Related]
15. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
Zhao XY; Li SS; He YX; Yan LJ; Lv F; Liang QM; Gan YH; Han LP; Xu HD; Li YC; Qi YY
Ann Rheum Dis; 2023 Oct; 82(10):1328-1340. PubMed ID: 37487609
[TBL] [Abstract][Full Text] [Related]
16. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
17. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
[TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome.
Zhao J; Wang J; Zhou M; Li M; Li M; Tan H
Int Immunopharmacol; 2019 Apr; 69():213-216. PubMed ID: 30738291
[TBL] [Abstract][Full Text] [Related]
20. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
Qi YY; Zhou XJ; Cheng FJ; Hou P; Ren YL; Wang SX; Zhao MH; Yang L; Martinez J; Zhang H
Ann Rheum Dis; 2018 Dec; 77(12):1799-1809. PubMed ID: 30209031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
